#PTT-121
Pyrotech Therapeutics Launches First Phase 1 Study of Innovative GSDMD Inhibitor to Combat Septic Shock#China#Beijing#Pyrotech#PTT-121#GSDMD
Pyrotech Therapeutics Launches First Phase 1 Study of Innovative GSDMD Inhibitor to Combat Septic Shock
Pyrotech Therapeutics has dosed its first subject in Phase 1 study of PTT-121, the first selective GSDMD inhibitor, aiming to tackle septic shock and inflammatory diseases.
third-news.com
September 1, 2026 at 12:18 PM
Parts 1-2/2 — EFTA00202807.jpg
#epsteinweb #efta00202807
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
April 24, 2026 at 4:52 AM
Parts 1-2/2 — EFTA01705554.jpg
#epsteinweb #efta01705554
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
March 7, 2026 at 12:37 PM
Parts 1-2/2 — EFTA01705528.jpg
#epsteinweb #efta01705528
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
March 7, 2026 at 12:36 PM
Parts 1-2/2 — EFTA01690699.jpg
#epsteinweb #efta01690699
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
March 7, 2026 at 12:24 AM
Parts 1-2/2 — EFTA01316315.jpg
#epsteinweb #efta01316315
https://epsteinweb.org
February 17, 2026 at 12:16 PM